Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer

International Journal of Gynecological Cancer

Volumn 17, Issue 6, 2007, Pages 1238-1244

  Harter, P ^a   Gnauert, K ^a   Hils, R ^a   Lehmann, T G ^a   Fisseler Eckhoff, A ^a   Traut, A ^a   Du Bois, A ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Lymph node metastases; Lymphadenectomy; Ovarian cancer; Primary surgery

Indexed keywords

ABDOMINAL AORTA; ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CYTOREDUCTIVE SURGERY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; EPITHELIAL OVARIAN CANCER; FEMALE; HUMAN; INFERIOR CAVA VEIN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OVARY CANCER; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; PREDICTOR VARIABLE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; CARCINOMA; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 35948952734     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00931.x     Document Type: Article

References (38)

1. Panici PB, Maggioni A, Hacker N et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 2005 97: 560 6.
2. Chambers SK. Systematic lymphadenectomy in advanced epithelial ovarian cancer: two decades of uncertainty resolved. J Natl Cancer Inst 2005 97: 548 9.
3. Tangjitgamol S, Manusirivithaya S, Sheanakul C et al. Can we rely on the size of lymph node in determing nodal metastasis in ovarian carcinoma? Int J Gynecol Cancer 2003 13: 297 302.
4. Isonishi S, Niimi S, Sasaki H. Drug-sensitivity related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer. Gynecol Oncol 2004 93: 647 52.
5. Crawford SC, Vasey PA, Paul J et al. Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial. J Clin Oncol 2005 23: 8802 11.
6. di Re F, Baiocchi G, Fontanelli R et al. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases. Gynecol Oncol 1996 62: 360 5.
7. Kikkawa F, Ishikawa H, Tamakoshi K et al. Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer. J Surg Oncol 1995 60: 227 31.
8. Yokoyama Y, Sakamoto T, Sato S, Saito Y. Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer. Eur J Gynaecol Oncol 1999 20: 361 6.
9. Kigawa J, Minagawa Y, Itamochi H et al. Retroperitoneal lymphadenectomy, including para-aortic nodes in patients with stage III ovarian cancer. Am J Clin Oncol 1994 17: 230 3.
10. Scarabelli C, Gallo A, Visentin MC et al. Systematic pelvic and para-aortic lymphadenectomy in advanced ovarian cancer patients with no residual intraperitoneal disease. Int J Gynecol Cancer 1997 7: 18 26.
11. du Bois A, Reuss A, Harter P et al. The role of lymphadenectomy in advanced epithelial ovarian cancer (AOC) in patients with macroscopically complete resection of intraperitoneal disease. Int J Gynecol Cancer 2006 16 (s3 601 (#0008).
12. Saygili U, Guclu S, Uslu T et al. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG study. J Surg Oncol 2002 81: 132 7.
13. Young RC, Decker DG, Wharton JT et al. Staging laparotomy in early ovarian cancer. J Am Med Assoc 1983 250: 3072 6.
14. du Bois A, Quinn M, Thigpen T et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 2005 16 (Suppl. 8 viii7 viii12.
15. Schmalfeldt B, du Bois A, Burges A et al. Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO. Zentralbl Gynakol 2006 128: 11 7.
16. Trimbos JB, Vergote I, Bolis G et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trial. J Natl Cancer Inst 2003 95: 113 25.
17. Munoz KA, Harlan LC, Trimble EL. Patterns of care for woman with ovarian cancer in the United States. J Clin Oncol 1997 15: 3408 15.
18. du Bois A, Rochon J, Lamparter C, Pfisterer J. Pattern of care and impact of participation in clinical studies on the outcome of ovarian cancer. Int J Gynecol Cancer 2005 15: 183 91.
19. Ayhan A, Gultekin M, Taskiran C et al. Lymphatic metastases in epithelial ovarian cancer with respect to clinicopathological variables. Gynecol Oncol 2005 97: 400 4.
20. Morice P, Joulie F, Camatte S et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 2003 197: 198 205.
21. Bidzinski M, Radziszewski J, Panek G, Danska-Bidzinska A. Risk of lymph node metastases in patients with ovarian cancer. Ginekol Pol 2003 74: 671 6.
22. Burghartd E, Girardi F, Lahousen M et al. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 1991 40: 103 6.
23. Cass I, Li AJ, Runowicz CD, Fields AL et al. Pattern of lymph node metastases in clinical unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol 2001 80: 56 61.
24. Carnino F, Fuda G, Ciccone G et al. Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 1997 65: 467 72.
25. Suzuki M, Ohwada M, Yamada T et al. Lymph node metastasis in stage I epithelial ovarian cancer. Gynecol Oncol 2000 79: 305 8.
26. Benedetti-Panici P, Greggi S, Maneschi F et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 1993 51: 150 4.
27. Petru E, Lahousen M, Tammusino K et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994 170: 656 62.
28. Tsumura N, Sakuragi N, Hareyama H et al. Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma. Int J Cancer 1998 23: 526 30.
29. Cliby WA, Aletti GD, Wilson TO, Podratz KC. Is it justified to classify patients to stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol 2006 103: 797 801.
30. Takeshima N, Hirai Y, Umayahara K et al. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Gynecol Oncol 2005 99: 427 31.
31. Negishi H, Takeda M, Fujimoto T et al. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol Oncol 2004 94: 161 6.
32. Triller J, Goldhirsch A, Fuchs WA. Value of computed tomography for the assessment of lymph node metastases in ovarian cancer. Rofo 1984 141: 35 9.
33. La Fianza A, Campani R, Dore R et al. The clinical value of computed tomography and lymphangography in detecting lymph node metastases from epithelial ovarian cancer. Rofo 1992 157: 162 6
34. Lorenzen M, Braun J, Gehrckens A, Nicolas V. Value of MRI, CT, and finding in staging of gynecologic malignancies. Aktuelle Radiol 1998 8: 266 72.
35. Williams AD, Cousins S, Soutter WP et al. Detection of lymph node metastases in gynecologic malignancy: a comparison of CT, MRI, and positron emission tomography. Am J Roentgenol 2002 178: 762.
36. Drieskens O, Stroobants S, Gysen M et al. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer. Gynecol Obstet Invest 2003 55: 130 4.
37. Bristow RE, Giuntoli II. RL, Pannu HK et al. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol 2005 99: 294 300.
38. Eisenkop SM, Spirtos NM. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer. Gynecol Oncol 2001 82: 143 9.